IP Library Granted Patent US 7,128,921
Granted Patent B1
US 7,128,921 · App. 09/662,293 · Granted Oct 31, 2006

Dermatophagoides proteins and fragments thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,128,921
App. No.
09/662,293
Granted
Oct 31, 2006
Kind
B1
Abstract

The present invention relates to high molecular weight Dermatophagoides proteins, nucleic acid molecules encoding such proteins, and therapeutic and diagnostic reagents derived from such proteins.

Claims (19)

1. An isolated protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO:15, SEQ ID NO:18 and SEQ ID NO:21.

2. A composition comprising the isolated protein of claim 1 .

3. A kit comprising the isolated protein of claim 1 .

4. An isolated protein encoded by a nucleic acid sequence comprising a sequence selected from the group consisting of SEQ ID NO:14, SEQ ID NO:17 and SEQ ID NO:20.

5. The isolated protein of claim 4 , wherein said protein is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NO:14, SEQ ID NO:17 and SEQ ID NO:20.

6. The isolated protein of claim 5 , wherein said isolated protein comprises an epitope having at least one identifying characteristic selected from the group consisting of:

(a) said epitope is resistant to β-elimination of peptides;

(b) said epitope is resistant to Proteinase-K digestion; and

(c) said epitope is reactive to a test designed to detect glycosylated proteins,

wherein an IgE selected from the group consisting of canine IgE from dogs allergic to mites and feline IgE from cats allergic to mites selectively binds to said epitope.

7. A composition comprising the isolated protein of claim 5 .

8. A kit comprising the isolated protein of claim 5 .

9. An isolated polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:18 and SEQ ID NO:21.

10. A composition comprising said isolated polypeptide of claim 9 .

11. A kit comprising said isolated polypeptide of claim 9 .

12. The isolated polypeptide of claim 9 , wherein said polypeptide consists of an amino acid sequence selected from the group consisting of SEQ ID NO:15, SEQ ID NO:18 and SEQ ID NO:21.

13. A fragment of the isolated polypeptide of claim 12 , wherein said fragment is at least 35 amino acids in length.

14. A composition comprising said polypeptide fragment of claim 13 .

15. A kit comprising said polypeptide fragment of claim 13 .

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Dec 14, 2023
From: JPMORGAN CHASE BANK, N.A.
To: HESKA CORPORATION; DIAMOND ANIMAL HEALTH, INC.; HESKA IMAGING, LLC
Reel/Frame 066012/0887 →
SECURITY INTEREST Recorded Oct 24, 2017
From: HESKA CORPORATION; DIAMOND ANIMAL HEALTH, INC.; HESKA IMAGING, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 044636/0972 →